149 related articles for article (PubMed ID: 33087273)
21. Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented Xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells.
Zhou NY; Bates SE; Bouziane M; Stary A; Sarasin A; O'Connor TR
J Mol Biol; 2003 Sep; 332(2):337-51. PubMed ID: 12948486
[TBL] [Abstract][Full Text] [Related]
22. Expression of a transfected DNA repair gene (XPA) in xeroderma pigmentosum group A cells restores normal DNA repair and mutagenesis of UV-treated plasmids.
Levy DD; Saijo M; Tanaka K; Kraemer KH
Carcinogenesis; 1995 Jul; 16(7):1557-63. PubMed ID: 7614689
[TBL] [Abstract][Full Text] [Related]
23. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
24. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
25. Xeroderma pigmentosum: beyond skin cancer.
Lichon V; Khachemoune A
J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
[TBL] [Abstract][Full Text] [Related]
26. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.
Fassihi H; Sethi M; Fawcett H; Wing J; Chandler N; Mohammed S; Craythorne E; Morley AM; Lim R; Turner S; Henshaw T; Garrood I; Giunti P; Hedderly T; Abiona A; Naik H; Harrop G; McGibbon D; Jaspers NG; Botta E; Nardo T; Stefanini M; Young AR; Sarkany RP; Lehmann AR
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1236-45. PubMed ID: 26884178
[TBL] [Abstract][Full Text] [Related]
27. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
28. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
31. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity.
Botta E; Nardo T; Broughton BC; Marinoni S; Lehmann AR; Stefanini M
Am J Hum Genet; 1998 Oct; 63(4):1036-48. PubMed ID: 9758621
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous angiosarcoma in a patient with xeroderma pigmentosum.
Arora R; Sharma A; Gupta R; Vijayaraghavan M
Indian J Pathol Microbiol; 2008; 51(4):504-6. PubMed ID: 19008576
[TBL] [Abstract][Full Text] [Related]
33. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
34. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F.
Yagi T; Tatsumi-Miyajima J; Sato M; Kraemer KH; Takebe H
Cancer Res; 1991 Jun; 51(12):3177-82. PubMed ID: 2039995
[TBL] [Abstract][Full Text] [Related]
35. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome.
Broughton BC; Thompson AF; Harcourt SA; Vermeulen W; Hoeijmakers JH; Botta E; Stefanini M; King MD; Weber CA; Cole J
Am J Hum Genet; 1995 Jan; 56(1):167-74. PubMed ID: 7825573
[TBL] [Abstract][Full Text] [Related]
36. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
38. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
39. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
Magnaldo T
Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
[TBL] [Abstract][Full Text] [Related]
40. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.
Fujimoto M; Leech SN; Theron T; Mori M; Fawcett H; Botta E; Nozaki Y; Yamagata T; Moriwaki S; Stefanini M; Momoi MY; Nakagawa H; Shuster S; Moss C; Lehmann AR
J Invest Dermatol; 2005 Jul; 125(1):86-92. PubMed ID: 15982307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
